Negative trials over and over again: How can we do better?
J Ricardo McFaline-Figueroa, Patrick Y. Wen
Abstract
Journal Article Negative trials over and over again: How can we do better? Get access J Ricardo McFaline-Figueroa, J Ricardo McFaline-Figueroa Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, USADivision of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital, Boston, USAHarvard Medical School, Boston, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Patrick Y Wen Patrick Y Wen Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, USADivision of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital, Boston, USAHarvard Medical School, Boston, USA Corresponding Author: Patrick Y. Wen, MD, Center For Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02420, USA ([email protected]). Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, Volume 25, Issue 1, January 2023, Pages 1–3, https://doi.org/10.1093/neuonc/noac226 Published: 18 October 2022 Article history Published: 18 October 2022 Corrected and typeset: 28 October 2022